NCT03963154View on ClinicalTrials.gov

Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

August 19, 2019

Primary Completion Date

June 22, 2023

Study Completion Date

December 15, 2026

Conditions
Retinitis Pigmentosa
Interventions
BIOLOGICAL

Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)

Implantation into one eye of hESC-derived RPE (Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE))

Trial Locations (1)

75012

•Centre Hospitalier National d'Ophtalmologie (CHNO) des Quinze-Vingts, Paris

All Listed Sponsors
lead

Centre d'Etude des Cellules Souches

OTHER

NCT03963154 - Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation | Biotech Hunter | Biotech Hunter